Aarthi Kannan - Concepedia

Author

Aarthi Kannan

Southern California Institute for Research and Education ORCID

Also Known As

A Kannan, A. Kannan, A. P. Gokula Kannan, Aarthi Kannan, Anandhi Kannan, Kannan A, Kannan, Aarthi

Publications

386

Citations

H-Index

Concepts

All Affiliations

Southern California Institute for Research and Education University of Arkansas for Medical Sciences University of California, Irvine VA Long Beach Healthcare System Huazhong University of Science and Technology

About

Aarthi Kannan is an author at Southern California Institute for Research and Education specializing in medicine, cancer research, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	243
2	Cell Biology	6	6	219
3	Pathology	4	4	85
4	Immunology	3	3	44
5	Medical Laboratory Science	1	1	10

Aarthi Kannan

Publications

357

Citations

H-Index

Page 1

	Year	Citations
Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma Deepanwita Sengupta, Aarthi Kannan, Malan Kern, Epigenetics Tumor BiologyChromatinPathologic C-myc ExpressionOncogenic AgentMedicine	2015	91
Transferrin receptor 1-mediated iron uptake regulates bone mass in mice via osteoclast mitochondria and cytoskeleton Bhaba Krishna Das, Lei Wang, Toshifumi Fujiwara, eLife	2022	60
Chronic mTOR activation promotes cell survival in Merkel cell carcinoma Zhenyu Lin, Amelia McDermott, Lijian Shao, Cancer Letters Chronic Mtor ActivationCell RegulationMedicinePathologyCell Death	2013	44
Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth Aarthi Kannan, Zhenyu Lin, Qiang Shao, Oncotarget Pi3k/mtor PathwayMedicineMerkel Cell CarcinomaCancer Cell BiologyMcc Tumor Growth	2015	40
Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts Bin Fang, Aarthi Kannan, Stephanie Zhao, Scientific Reports	2020	27
A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: Potential impact on CTL epitopes Alagarsamy Srinivasan, Velpandi Ayyavoo, Sundarasamy Mahalingam, Virology Journal	2008	17
Circulating tumor DNA as a predictive biomarker in Merkel cell carcinoma Soo Jung Park, Aarthi Kannan, Jeremy P. Harris, Journal of the American Academy of Dermatology ImmunologyImmunoeditingPathologyImmunotherapeuticsImmunotherapy	2022	17
Single-cell dissection of Merkel cell carcinoma heterogeneity unveils transcriptomic plasticity and therapeutic vulnerabilities Bhaba Krishna Das, Aarthi Kannan, Graham J. Velasco, Cell Reports Medicine ImmunologyImmunotherapyTumor BiologyTumor HeterogeneitySingle-cell Dissection	2023	17
Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient John Yeakel, Aarthi Kannan, Nicole Hook Rattigan, JAAD Case Reports Biomarker (Medicine)OncologyCancer DetectionMedicineBiomarker Target	2021	14
Evaluation of clinical, biochemical and hematological parameters in macrocytic anemia Aarthi Kannan, Vijai Tilak, Madhukar Rai, International Journal of Research in Medical Sciences AnemiaHematological MalignancyMacrocytic AnemiaLaboratory HematologyBone Marrow Failure	2016	10

Page 1